» Business » US regulator urges USV to probe staff for inaccurate data reporting

US regulator urges USV to probe staff for inaccurate data reporting

By Sushmi Dey
March 05, 2014 14:05 IST
Get Rediff News in your Inbox:

In a recent warning letter to domestic drug maker USV Ltd for violations in manufacturing practices, the US Food and Drug Administration (FDA) has asked the company to identify the “historical period” during which the violations occurred at the firm’s Mumbai facility.

This photograph is for representation purpose only Pointing out data integrity-related issues, the US regulator also asked the company’s consultant to identify and interview current and former employees who might have been responsible for inaccurate data reporting.

The warning letter, dated February 6 and sent to USV Ltd’s managing director Prashant Kumar Tewari, highlighted the “lack of reliability and accuracy of data generated” by the firm.

An email sent to USV Ltd did not elicit any response.

The letter has made the domestic pharmaceuticals sector jittery, as it is indicative of stringent directives by the regulator in the future.

“It is a uniquely drafted letter. The usual practice is to only talk about the violations in the facility and the observations by the regulator. Though the regulator also briefly talks about the steps required, it never details it in the manner done in this letter,” a senior official at a leading pharmaceuticals company told Business Standard

The sector is also concerned about the regulator’s directive to USV to identify and interview employees.

Get Rediff News in your Inbox:
Sushmi Dey in New Delhi
Source: source

Moneywiz Live!